Pennsylvania Controlled Substance Prescription Requirements

A controlled substance prescription written in Pennsylvania has to carry a defined set of patient and prescriber details, move electronically from the prescriber’s system to the pharmacy in almost every case, and be preceded by a check of the state’s prescription monitoring database. Those are the core Pennsylvania controlled substance prescription requirements, and they come from a mix of federal DEA rules, the Pennsylvania Controlled Substance, Drug, Device and Cosmetic Act, and newer state laws aimed at opioids. Miss any piece and the pharmacy will send the script back.

Information the Prescription Must Contain

Federal DEA regulations set the floor. Under 21 CFR § 1306.05, every controlled substance prescription must show the date of issuance, the patient’s full name and address, the drug name, strength, dosage form, quantity, and directions for use, plus the practitioner’s name, address, DEA registration number, and signature.¹

Pennsylvania’s Board of Pharmacy adds its own layer in 49 Pa. Code § 27.18. Every prescription on file must display the patient’s name and address, the prescriber’s name and address or other identifier, the date, the drug name and quantity, and directions for use. For a controlled substance, the prescriber’s DEA number must appear as well. Schedule II prescriptions have to be written in ink, indelible pencil, typewriter, or by electronic means, and must be signed by the prescriber.²

A wrong or missing DEA number is one of the fastest routes to a rejected prescription, because it’s the credential that ties the prescriber to their authority to write for scheduled drugs. Illegible fields fail for the same reason.

Electronic Prescribing Is the Defaulth2>

Since October 2019, Pennsylvania has required nearly all Schedule II through V prescriptions to be transmitted electronically from the prescriber’s clinical software directly to the pharmacy. The mandate comes from Act 96 of 2018 and applies to every practitioner other than veterinarians.³ The Controlled Substance, Drug, Device and Cosmetic Act reinforces the same rule, barring dispensing of a Schedule II drug without an electronic prescription and extending the requirement to Schedules III through V.⁴

Paper is still permitted in three defined situations:

A temporary technological or electrical failure makes electronic prescribing unavailable. If the underlying problem is reasonably within the prescriber’s control, they have to attempt to fix it within 72 hours.

A practitioner in an emergency department or other healthcare facility determines that an electronic prescription would be impractical for the patient or would cause a delay that could harm the patient’s condition.

The patient is enrolled in a hospice program or resides in a nursing home or residential healthcare facility.

These carve-outs keep patients in crisis or in institutional care from being stuck waiting on a system outage.³

Emergency Verbal Orders for Schedule II

In a true emergency, a practitioner can phone in a Schedule II prescription to a pharmacy. Federal rules require the prescriber to follow up with a written prescription delivered to the pharmacy within seven days. If the pharmacy partially fills the emergency oral order, the remaining portions must be filled within 72 hours.⁵

PDMP Query Before Writing

Before writing a controlled substance prescription, Pennsylvania practitioners must query the state’s Prescription Drug Monitoring Program, the database created by the Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act. The database tracks controlled substance prescriptions filled at every pharmacy in the Commonwealth, so a patient collecting similar drugs from multiple prescribers and multiple pharmacies is visible at a glance.

The check protects the patient (by revealing dangerous combinations already in play) and the prescriber (by documenting due diligence). Skipping it exposes the prescriber to professional discipline from their licensing board.

Refills and How Long a Prescription Stays Valid

Refill rights and validity turn entirely on the drug’s schedule. Pennsylvania tracks the federal framework:

Schedule II drugs such as oxycodone, fentanyl, and amphetamine cannot be refilled. The prescription expires six months from the date written. Each time the patient needs more, the prescriber has to issue a new prescription.
Schedule III, IV, and V drugs, including certain codeine combinations, benzodiazepines, and pregabalin, can be refilled up to five times within six months of the original date. Whichever limit is reached first ends the prescription.

Both federal regulation and Pennsylvania’s pharmacy standards codify these limits.⁶²

Multiple Schedule II Prescriptions at One Visit

Because Schedule II drugs can’t be refilled, federal rules let a practitioner write multiple prescriptions at a single visit covering up to a 90-day supply. Each prescription must carry a “do not fill until” date. The prescriber can only do this if they judge it won’t create undue risk of diversion or abuse, and Pennsylvania law must permit the practice.⁶

Partial Fills on Schedule II

A patient or prescriber can request that the pharmacy dispense less than the full quantity on a Schedule II prescription. Under 21 U.S.C. § 829(f), the remaining portion can be filled later, but the entire quantity must be dispensed within 30 days of the original prescription date.⁵ This is useful after surgery when a patient wants to start with a smaller amount and only return for the rest if needed.

Extra Rules for Opioid Prescriptions

On top of the general controlled substance rules, Pennsylvania has enacted opioid-specific restrictions that vary by setting and patient age.

Emergency Departments and Urgent Care

Act 122 of 2016, the Safe Emergency Prescribing Act, limits how much opioid supply a hospital emergency department or urgent care center can dispense. The law targets settings where the prescriber typically has no ongoing relationship with the patient and limited visibility into their medication history.

Patients Under 18

Act 125 of 2016 caps opioid prescriptions for anyone under 18 at a seven-day supply. Before the first opioid prescription in a course of treatment, the prescriber must discuss the risks of addiction and overdose with both the minor and a parent or guardian, including the danger of combining opioids with benzodiazepines or alcohol. Written consent from a parent, guardian, or authorized adult is required before the prescription is issued.⁷

The seven-day cap has documented exceptions. A prescriber may authorize a longer supply for cancer pain management, for palliative or hospice care, for chronic pain not associated with cancer, or for an acute condition requiring stabilization. In the acute case, the record must document the condition and explain why a non-opioid alternative is not appropriate.⁷

Telehealth Prescribing

Federal rules ordinarily require an in-person evaluation before a practitioner can prescribe a controlled substance. The DEA has extended COVID-era telehealth flexibilities through December 31, 2026, allowing Schedule II through V controlled substances to be prescribed through an audio-video telemedicine encounter without an in-person exam. The prescription still has to serve a legitimate medical purpose and meet every other federal and state requirement.⁸

A separate permanent rule took effect at the end of 2025 specifically for buprenorphine prescribed to treat opioid use disorder. That rule allows telemedicine prescribing of buprenorphine without an in-person visit, provided the practitioner uses synchronous audio-visual technology and meets certain documentation requirements.

Pennsylvania’s electronic prescribing mandate still applies. A controlled substance ordered during a video visit must be transmitted electronically to the pharmacy, the same as one written in an exam room.

Photo ID at the Pharmacy Counter

Most Pennsylvania pharmacies ask for a government-issued photo ID when a patient picks up a controlled substance, especially in Schedule II. The statutory basis for a universal photo ID mandate is less definite than many people assume. The Controlled Substance, Drug, Device and Cosmetic Act contains explicit photo ID requirements for purchases of products containing ephedrine or pseudoephedrine, but Section 11’s controlled substance dispensing provisions focus on prescriber and electronic transmission rules rather than a blanket patient ID requirement.⁴

In practice, the source of the rule doesn’t change the outcome at the counter. Whether it’s state law, federal guidance, corporate policy, or the pharmacist’s professional judgment, no ID means no medication. A driver’s license, state ID card, military ID, or passport is accepted at any pharmacy.

1
eCFR. 21 CFR 1306.05 – Manner of Issuance of Prescriptions
2
Legal Information Institute. Pennsylvania Code 49 Pa. Code 27.18 – Standards of Practice
3
Pennsylvania Department of Health. Electronic Prescribing of Controlled Substances Frequently Asked Questions
4
Pennsylvania General Assembly. The Controlled Substance, Drug, Device and Cosmetic Act
5
Office of the Law Revision Counsel. 21 USC 829 – Prescriptions
6
eCFR. 21 CFR 1306.12 – Refilling Prescriptions; Issuance of Multiple Prescriptions
7
Pennsylvania General Assembly. Pennsylvania Consolidated Statutes Title 35 Chapter 52A – Prescribing Opioids to Minors
8
DEA. DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care